Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis

American Journal of Pathology - United States
doi 10.2353/ajpath.2006.050610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficiency Is Compatible With Murine Life

Journal of Clinical Investigation
Medicine
2002English

Biochemical Characterization of Bovine Plasma Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)

2011English

Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular Inflammation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2016English

Thrombin Interacts With Thrombomodulin, Protein C, and Thrombin-Activatable Fibrinolysis Inhibitor via Specific and Distinct Domains

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Correlate With the Disease Activity of Ulcerative Colitis

Internal Medicine
Internal MedicineMedicine
2016English

IGF1R Deficiency Attenuates Acute Inflammatory Response in a Bleomycin-Induced Lung Injury Mouse Model

Scientific Reports
Multidisciplinary
2017English

Increased Plasminogen Activator Inhibitor-1, Decreased Tissue Factor Pathway Inhibitor, and Unchanged Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients With Primary Hyperparathyroidism

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy